Related Experiment Video

Updated: Jun 23, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer

Sachin Kumar, Vikas Singh, Subhash Chandra

    Lung Cancer (Amsterdam, Netherlands)
    |April 29, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS
    07:33

    Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS

    Published on: December 21, 2011

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    Assessment of Vascular Function in Patients With Chronic Kidney Disease
    08:50

    Assessment of Vascular Function in Patients With Chronic Kidney Disease

    Published on: June 16, 2014

    Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS
    07:33

    Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS

    Published on: December 21, 2011

    Related Concept Videos

    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    Systematic misclassification of lung function in Indian adolescents using GLI-2012 reference equations: evidence from the multicity APEAL cohort.

    Thorax·2026

    Eosinophilic pleural effusion in an individual in a high tuberculosis-burden country.

    Breathe (Sheffield, England)·2026

    Spatial transcriptomics of primary and metastatic ALK-rearranged NSCLC reveals site-specific adaptations.

    Current problems in cancer·2026

    Glycaemic burden disrupts innate immunity in TB by modulating CD206 expression and macrophage antimicrobial responses.

    Tuberculosis (Edinburgh, Scotland)·2026

    Safety and efficacy of inhaled itraconazole in adults with asthma and allergic bronchopulmonary aspergillosis (PUR1900-ABPA): a randomized, double-blind, parallel group, placebo-controlled, multicenter, phase 2 trial.

    The European respiratory journal·2026

    Brief Report: Translating Selection Criteria for Lung Cancer Screening to an Indian Context-An Analysis From a Tertiary Health Centre.

    JTO clinical and research reports·2026

    Lung cytology in the diagnostic workflow: A real-world study of its clinical impact.

    Lung cancer (Amsterdam, Netherlands)·2026

    Trial-specific absolute disease-free survival effects of postoperative PD-1/PD-L1 blockade after complete resection of NSCLC: A systematic review.

    Lung cancer (Amsterdam, Netherlands)·2026

    Exploratory analysis of extracellular vesicle Profile changes during pembrolizumab treatment in NSCLC.

    Lung cancer (Amsterdam, Netherlands)·2026

    Second-line therapy in extensive-stage small cell lung cancer: an unmet need highlighted by real-world evidence from the LALUCA registry.

    Lung cancer (Amsterdam, Netherlands)·2026

    Lung cancer after allogeneic hematopoietic stem cell transplantation.

    Lung cancer (Amsterdam, Netherlands)·2026

    Systemic and intracranial activity of antibody-drug conjugates in patients with non-small cell lung cancer and brain metastases: A systematic review and meta-analysis.

    Lung cancer (Amsterdam, Netherlands)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us